Literature DB >> 11328378

Analysis of recombinant mycobacteria as T helper type 1 vaccines in an allergy challenge model.

R Janssen1, A Kruisselbrink, L Hoogteijling, J R Lamb, D B Young, J E Thole.   

Abstract

The potential for development of mycobacteria as T helper type 1 (Th1) vaccines capable of induction of Th1 responses to recombinant antigens was explored in a model system based on an immunodominant peptide from house dust mite. Different recombinant mycobacterial preparations were compared for their ability to induce a Th1 response to the peptidea. It was found that mycobacterial viability was not a prerequisite for Th1 immunogenicity. A dominant interferon-gamma (IFN-gamma) response to peptide was observed in splenocytes from C57BL/6J mice immunized with live or heat-killed preparations of recombinant Mycobacterium vaccae or with live attenuated bacillus Calmette-Guèrin (BCG) vaccine expressing the antigen. Interleukin-5 (IL-5), a marker of a Th2 response, was detected only in mice receiving live M. vaccae. A similar pattern was observed in BALB/b mice, although the magnitude of the IFN-gamma response was much lower. Control and immunized mice were subsequently exposed to allergen using a Th2-inducing challenge protocol. A significant shift from a Th2 to a Th1 response was observed in immunized mice, as judged by cytokine expression by splenocytes and by subclass of circulating antibody. The effect was seen in three inbred mouse strains differing in their innate bias towards Th1 or Th2 responses. It was dependent on the presence of specific antigen in the mycobacterial preparation and, under the immunization conditions tested, was more pronounced with dead M. vaccae than with live BCG as carrier vaccine. The results demonstrate the potency of killed mycobacteria as Th1 adjuvants and suggest a potential application for recombinant mycobacteria in antigen-specific immune modulation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11328378      PMCID: PMC1783193          DOI: 10.1046/j.1365-2567.2001.01207.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  41 in total

Review 1.  Mycobacterial protein antigens: a compilation.

Authors:  D B Young; S H Kaufmann; P W Hermans; J E Thole
Journal:  Mol Microbiol       Date:  1992-01       Impact factor: 3.501

2.  Comparison of antigen presentation by lymph node cells from protein and peptide-primed mice.

Authors:  G F Hoyne; M G Callow; M C Kuo; W R Thomas
Journal:  Immunology       Date:  1993-01       Impact factor: 7.397

3.  Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late-phase cutaneous responses.

Authors:  V A Varney; Q A Hamid; M Gaga; S Ying; M Jacobson; A J Frew; A B Kay; S R Durham
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

4.  Humoral and cell-mediated immune responses to live recombinant BCG-HIV vaccines.

Authors:  A Aldovini; R A Young
Journal:  Nature       Date:  1991-06-06       Impact factor: 49.962

5.  Efficacy of BCG vaccine against leprosy and tuberculosis in northern Malawi.

Authors:  J M Pönnighaus; P E Fine; J A Sterne; R J Wilson; E Msosa; P J Gruer; P A Jenkins; S B Lucas; N G Liomba; L Bliss
Journal:  Lancet       Date:  1992-03-14       Impact factor: 79.321

6.  Patterns of cytokine production by mycobacterium-reactive human T-cell clones.

Authors:  P F Barnes; J S Abrams; S Lu; P A Sieling; T H Rea; R L Modlin
Journal:  Infect Immun       Date:  1993-01       Impact factor: 3.441

7.  New use of BCG for recombinant vaccines.

Authors:  C K Stover; V F de la Cruz; T R Fuerst; J E Burlein; L A Benson; L T Bennett; G P Bansal; J F Young; M H Lee; G F Hatfull
Journal:  Nature       Date:  1991-06-06       Impact factor: 49.962

8.  Allergen- and bacterial antigen-specific T-cell clones established from atopic donors show a different profile of cytokine production.

Authors:  P Parronchi; D Macchia; M P Piccinni; P Biswas; C Simonelli; E Maggi; M Ricci; A A Ansari; S Romagnani
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-15       Impact factor: 11.205

9.  Characterization of T-cell responses to the house dust mite allergen Der p II in mice. Evidence for major and cryptic epitopes.

Authors:  G F Hoyne; M G Callow; M C Kuo; W R Thomas
Journal:  Immunology       Date:  1993-01       Impact factor: 7.397

10.  Protective immunity elicited by recombinant bacille Calmette-Guerin (BCG) expressing outer surface protein A (OspA) lipoprotein: a candidate Lyme disease vaccine.

Authors:  C K Stover; G P Bansal; M S Hanson; J E Burlein; S R Palaszynski; J F Young; S Koenig; D B Young; A Sadziene; A G Barbour
Journal:  J Exp Med       Date:  1993-07-01       Impact factor: 14.307

View more
  5 in total

1.  Immunogenicity of a protective whole cell mycobacterial vaccine in HIV-infected adults: a phase III study in Tanzania.

Authors:  Timothy Lahey; Robert D Arbeit; Muhammad Bakari; C Robert Horsburgh; Mecky Matee; Richard Waddell; Lillian Mtei; Jenni M Vuola; Kisali Pallangyo; C Fordham von Reyn
Journal:  Vaccine       Date:  2010-09-25       Impact factor: 3.641

Review 2.  The potential of Mycobacterium to protect against allergy and asthma.

Authors:  Charles C Obihara; Jan L L Kimpen; Nulda Beyers
Journal:  Curr Allergy Asthma Rep       Date:  2007-06       Impact factor: 4.806

Review 3.  Recent advances in treatment strategies for atopic dermatitis.

Authors:  Thomas Christian Roos; Stefan Geuer; Sabine Roos; Harald Brost
Journal:  Drugs       Date:  2004       Impact factor: 9.546

4.  The contribution of microglia to "immunization against stress".

Authors:  Miles Herkenham
Journal:  Brain Behav Immun       Date:  2018-08-03       Impact factor: 7.217

5.  Suppression of allergic airway inflammation in a mouse model by Der p2 recombined BCG.

Authors:  Hai-Feng Ou-Yang; Xing-Bin Hu; Xin-Yu Ti; Jie-Ran Shi; Shu-Jun Li; Hao-Wen Qi; Chang-Gui Wu
Journal:  Immunology       Date:  2008-12-22       Impact factor: 7.397

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.